Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SYRE
SYRE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SYRE News
Spyre Therapeutics Prices Public Offering at $62 per Share
6d ago
NASDAQ.COM
Spyre Therapeutics Upsizes Public Offering to Raise $403 Million
6d ago
seekingalpha
Spyre Therapeutics Prices $403 Million Public Offering
6d ago
Yahoo Finance
Spyre Therapeutics Prices Public Offering at $62 per Share
6d ago
Newsfilter
Spyre Therapeutics Launches $300 Million Public Offering
Apr 14 2026
NASDAQ.COM
Spyre Therapeutics Launches $300M Public Offering to Fund Drug Development
Apr 13 2026
seekingalpha
Spyre Therapeutics Launches $300 Million Public Offering
Apr 13 2026
Newsfilter
Spyre Therapeutics' Trial Data Boosts Stock by 23%
Apr 13 2026
stocktwits
Biotech Stocks Reach New 52-Week Highs
Apr 09 2026
NASDAQ.COM
Spyre Therapeutics CEO Sells Shares Worth $740K
Apr 08 2026
Fool
Spyre Therapeutics CEO Sells Shares Worth $740K
Apr 08 2026
NASDAQ.COM
Spyre Therapeutics Grants Stock Options to Employees
Apr 03 2026
Newsfilter
VR Adviser, LLC Increases Stake in Spyre Therapeutics by 1 Million Shares
Mar 19 2026
NASDAQ.COM
VR Adviser Increases Stake in Spyre Therapeutics by 1 Million Shares
Mar 19 2026
Fool
VR Adviser, LLC Reduces Stake in Ocular Therapeutix
Mar 18 2026
Fool
VR Adviser, LLC Sells Shares of Ocular Therapeutix
Mar 18 2026
NASDAQ.COM
Show More News
